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ABSTRACT 
 
Melissa officinalis is a plant growing and cultivated in some parts of Iran. The leaves of lemon balm, M. officinalis 
L. (Lamiaceae) are used in Iranian folk medicine for their digestive, carminative, antispasmodic, sedative, 
analgesic, tonic and diuretic as well as for functional gastrointestinal disorders. The aim of this study was to 
overview its therapeutic effects than its nutritive and industrial effects. This review article was carried out by 
searching studies in PubMed, Medline, Web of Science, and Iran Medex databases .The initial search strategy 
identified about 128 references. In this study, 113 studies was accepted for further screening and met all our 
inclusion criteria [in English, full text, therapeutic effects of Melissa officinalis L and dated mainly from the year 
1964 to 2015.The search terms were “Melissa officinalis L.”, lemon balm, “therapeutic 
properties”,“pharmacological effects”. It is commonly used for its anti-herpes and anti-viral and anti-HIV, 
antioxidant, antimicrobial, anticancer and anti- tumor, anti-stress and anti-anxiolytic and antidepressant, anti-
Alzheimer, anti-cardiovascular diseases, memory improving and concentration, anti-inflammatory effects.It was 
said to be good for insomnia and dyssomina. Melissa officinalis l.  is widely used for therapeutic and non-
therapeutic purposes that trigger its significant value. Various combinations and numerous medicinal properties of 
its extract,   oil, and leaves demand further and more studies about the other useful and unknown properties of this 
multipurpose plant. 
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INTRODUCTION 
 
Melissa officinalis L. also known as lemon balm, bee balm, honey balm[1], is a perennial herb[2] belonging to 
Lamiaceae family[3, 4].it is native to southern Europe and northern Africa, Caucasus and northern Iran [5], the 
Eastern Mediterranean region and Western Asia, as well as tropical countries [Brazil][6]. In Iran, this plant is known 
locally by the names Badranjbooye, Varangboo and Faranjmoshk[7]. 
 
Historically lemon balm has been said to possess sedative/tranquilizing, anti-gas, fever-reducing, antibacterial, 
spasmolytic, hypotensive, memory-enhancing, menstrual-inducing, and thyroid-related effects [8-10],spasmolytic, 
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nervous sedative[11], its oil  has been reported as having antibacterial, antifungal, antiparasitic and antispasmolytic 
activities[12, 13]. It was used in the Iranian traditional system of medicine for the treatment of headaches, flatulence, 
indigestion, colic, nausea, nervousness, anemia, vertigo, syncope, malaise, asthma, bronchitis, amenorrhea, cardiac 
failure, arrhythmias, insomnia, epilepsy, depression, psychosis, hysteria, ulcers and wounds[14]. it has therapeutic 
properties, such as sedative, carminative and antispasmodic properties; it was used for treatment of headache, 
rheumatism, indigestion and hypersensitivities [15]. 
 
 It was commonly used for its anti-angiogenic[16],antioxidant[17-23] , antimicrobial[24, 25]  , anticancer[26-30], 
Antidysrhythmic[31] anti-stress and anti-anxiolytic [32-36],anti-herpes and anti-viral[37-45]anti- tumor, anti-
Alzheimer[11, 46-51], anti-diabetic [52],antidepressant[53, 54] anti-cardiovascular diseases [54-57],memory 
improving [51, 58],anti-HIV[59],anti-inflammatory[60].It was said to be good for insomnia and dyssomina[61-63], 
concentration [64], antihyperlipidemic activities and effects [65]. 
 
Chemical compounds 
the main constituent of the lemon balm were shown  to be hydroxycinnamic acid derivatives, particularly rosmarinic 
acid, caffeic acids, chlorogenic acid, and metrilic acid[66-71] ,tannins[72-76], flavonoids, including luteolin, luteolin 
7-O-beta-D-glucopyranoside, apigenin 7-O-beta-D-glucopyranoside, and luteolin 3-O-beta-D-
glucuronopyranoside[77-83], monoterpene glycosides[84], sesquiterpenes, including β-caryophyllene and 
germacrene[84]triterpenes[85]and volatile oils, including citronellal, citral a (geranial), citral b (neral), methyl 
citronellate, ocimene, citronellol, geraniol, nerol, β-caryophyllene, β-caryophyllene oxide, linalool, and ethric oil[79, 
80, 86-90] . 
 
The volatile oil comprises 0.5-0.1% of the plant by weight, and citronellal, geranial, and neral constitute about 50-
70% of this oil[86]. Eugenyl glycoside has been isolated from lemon balm leaves[91]. The chemical composition of 
lemon balm tea yielded 10 mg/L of essential oil (74% citral)and large amounts of polyphenol compounds[92]. 
Steam distillates of lemon balm callus cultures yielded dehydroabietane and another diterpene hydrocarbon, with the 
relative proportion of those two compounds varying considerably during cultivation passage[93]. 
 
The constituent of the essential oil of the plant in various climates is different, but citral(geranial and neral), 
citronellal, geraniol are main components. Many parameters influencing essential oil composition and yield, such as 
light intensity, nutrient, temperature, cultural practice genotype, plant part age, harvesting time[94]. The chemical 
composition of the essential oil of the plant leaf has also been studied. The major compounds were citronellal, citral 
and β-caryophyllene. Citral is a mixture of two monoterpenes, geranial and neral. Due to its intense lemon aroma 
and flavour, citral is used widely in foods and cosmetics[95].Also some flavonoids such as luteolin-7-o-
glucoside(0.0002%).The lemon balm extract contained hydroxycinnamic acid derivatives and flavonoids with 
caffeic acid, m-coumaric acid,eriodictyol-7-O-glucoside, naringin, hesperidin, rosmarinic acid, naringenin, 
hesperetin being identified[96]. 
 
Mechanisms of action 
Lemon balm has shown to possess high phenolics content and antioxidant properties[97].Lemon balm extracts and 
rosmarinic acid have both been  demonstrated to enjoy antioxidant properties in vitro[4, 66, 70], and rosmarinic acid 
and caffeic acid have demonstrated significant antioxidant and immune modulating activities[70, 71, 98-100]. 
During linoleic acid autoxidation and its EDTA-mediated oxidation, lemon balm showed antioxidant activity[101]. 
Some other antioxidant activity of lemon balm has been shown as evidenced by the reduction of 1,1-diphenyl-2- 
picrylhydrazyl(DPPH)[102]. Studies have demonstrated that the cytoprotective effect of lemon balm extracts seen in 
rats was partly due to [92]free-radical scavenging properties[77, 98] . Immunostimulation effects of a lemon balm 
extract were also demonstrated[103]. Inhibitory effects of rosmarinic acid from lemon balm on porcine pancreatic 
amylase were reported in vitro[104].   
 
A novel pharmacological mechanism of action for the anxiolytic botanical Melissa officinalis L. (lemon balm) is 
reported. The methanol extract was identified as a potent in vitro inhibitor of rat brain GABA transaminase (GABA-
T), an enzyme target in the therapy of anxiety, epilepsy and related neurological disorders. Bioassay-guided 
fractionation led to the identification and isolation of rosmarinic acid [RA] and the triterpenoids, ursolic acid (UA) 
and oleanolic acid (OA) as active principles. Phytochemical characterization of the crude extract determined RA as 
the major compound responsible for activity (40% inhibition at 100 microg/mL) since it represented approximately 
1.5% of the dry mass of the leaves. Synergistic effects may also play a role[105]. 
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Antiherpes and anti-HIV effect 
the virucidal and antiviral effects of Melissa officinalis L. extracts (M1, M3, M3 and M4) with respect 
to Herpes simplex virus type 1 was investigated and it was demonstrated that there was no significant values of 
inhibiting activity of M1, M2, and M3 on the same virus in vitro or in vivo. Caffeic, rosmarinic and ferulic acids 
contribute to  antiviral activity of M. officinalis L. [44]. In an in vitro study, anti-herpes activity of Melissa officials 
was investigated and it was suggested that the Melissa extract demonstrated a high virucidal activity against HSV-1, 
even at very low concentrations of 1.5 µg/ml. [41]. A hydroalcoholic extract of lemon balm leaves was investigated 
against the Herpes simplex virus type 2 (HSV-2) in comparison with acyclovir. Lemon balm showed to reduce the 
cytopathic effect of HSV-2 on Vero cells, in the range of non-toxic concentrations [38]. 
 
A specially prepared dried extract from Melissa leaves was investigated in a double-blind study and the antiviral 
activity of this plant against herpes simplex infections was in vitro confirmed. Besides, the treatment with this plant 
was shown to be effective at very early stages of the infection [43].A double-blind, placebo-controlled, randomized 
trial was carried out with the aim of proving efficacy of standardized balm mint cream for the therapy 
of herpes simplex labialis. The tested formulation is effective for the treatment of herpes simplex labialis[42]. 
Aqueous extracts from leaves of this plant were examined for its inhibitory effect against immunodeficiency virus 
type 1 (HIV-1) in a clinical trial study. Aqueous extracts from Lamiaceae was found to reduce the infectivity of 
HIV-1 virions at non-cytotoxic concentrations rapidly. Its mechanism of action seems to be its  enhancement of the 
virion's density before  its surface engagement [59]. 
 
In an animal study, the antiviral effect of lemon balm oil of Melissa officinalis, on herpes simplex virus (HSV-
1)(HSV-2)was examined and it was suggested that  Melissa oil affected the virus before adsorption, but not after 
penetration into the host cell, thus lemon balm oil is capable of exerting a direct antiviral effect on herpes 
viruses[40]. 
 
Antioxidant effects 
The leaf material of lemon balm was extracted and was investigated for potential in vitro antioxidant properties. It 
was demonstrated that the lemon balm extract has the ability to scavenge both synthetic and natural free radicals. 
This is of significant importance as it indicates that the extract may have the potential to prevent oxidative damage 
in vivo by preventing free radical-mediated oxidative stress. Due to its iron (II) chelating activity of the extract, its 
antioxidant potential was increased[96]. 
 
Lemon balm was analyzed to determine their antioxidant activity and content of total phenolics, L-ascorbic acid, and 
carotenoids. The ability to scavenge the free radical DPPH (2,2-diphenyl-1-picrylhydrazyl) was very high in almost 
all tested samples[106]. 
 
In an animal study, the efficacy of aqueous extract of Melissa officinalis was investigated in decreasing manganism -
induced brain oxidative stress in mice. The results was indicated that M. officinalis aqueous extract possesses potent 
antioxidative and neuroprotective properties, validating its efficacy in attenuating Mn-induced oxidative stress in the 
mouse brain[107]. Antioxidant activity of this plant was examined in lots of other studies and was confirmed [20, 
108]. 
 
Anti- Alzheimer and Neuroprotective Effects 
The efficacy of Melissa aromatherapy in the treatment of patients with Alzheimer's disease was assessed in a 
blinded randomized controlled trial comparing it with donepezil. It was shown that there is no evidence that 
Melissa aromatherapy has priority to donepezil in this case. Nonetheless, the remarkable improvement in the 
placebo group emphasizes the potential non-specific benefits of this plant in the treatment of these patients.[109]. 
In another study, the acute effects on cognition and mood of a standardized extract of M. officinalis was 
investigated. It was demonstrated that utilizing the cognitive factors previously derived from the CDR battery, 
included a sustained improvement in Accuracy of Attention following 600 mg of Melissa and time- and dose-
specific reductions in both Secondary Memory and Working Memory factors. Self-rated "calmness," as assessed by 
Bond-Lader mood scales, was elevated at the earliest time points by the lowest dose, whilst "alertness" was 
significantly reduced at all-time points following the highest dose. Both nicotinic and muscarinic binding were 
found to be low in comparison to the levels found in previous studies.[36]. 
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The efficacy and safety of Melissa officinalis extract using a fixed dose (60 drops/day) in patients with mild to 
moderate Alzheimer's disease were examined. At four months, Melissa officinalis extract produced a significantly 
better outcome on cognitive function than placebo. There were no significant differences in the two groups in terms 
of observed side effects except agitation, which was more common in the placebo group [p = 0.03].thus, it was 
concluded that Melissa officinalis extract is of value in the management of mild to moderate Alzheimer's disease and 
has a positive effect on agitation in such patients[110]. 
 
In another study, cholinergic antagonists were recorded for their amnesic and dementia-inducing properties of 
Melissa were examined[111].The extract of Melissa officinalis have been studied on the amelioration of Alziethmer 
symptoms. The mechanisms involved in this amelioration of this disease including acetylcholinesterase(AChE) 
inhibition, modification of monoamines, antiamyloid aggregation effect, and antioxidant activity were summarized 
in a study and the anti- Alzheimer effect of Melissa was confirmed[48]. Melissa officinalis, extracts have been 
demonstrated to be useful for dementia, both alone or in combination[34]. The possible 
neuroprotective effects of total ethanolic extract, acidic and nonacidic fraction of Melissa officinalis on Aβ-induced 
cytotoxicity and oxidative stress in PC12 cells were assessed and also their in-vitro anticholinesterase activity were 
measured.  
 
Theprotective effects of Melissa officinalis total extract and acidic fraction were not attributed to their 
anticholinesterase activity. Acidic fraction showed more potent protective effect compared to the total extract, 
leading to the fact that polyphenolic compounds and terpenoic acids were the most effective components in 
the total extract concentrated in this fraction[46].Effect of Melissa officinalis on hypoxia induced neuronal death in a 
cortical neuronal culture system as in vitro model and transient hippocampal ischemia as in vivo model was 
investigated. Results showed that Melissa officinalis could be considered as a protective agent in various 
neurological diseases associated with ischemic brain injury[47].The neuroprotective effects of Melissa officinalis 
was investigated against neuron toxicity in hippocampal primary culture induced by 3,4-
methylenedioxymethamphetamine (MDMA) or ecstasy. A high dose of ecstasy caused profound mitochondrial 
dysfunction, around 40% less than the control value, and increased apoptotic neuronal death to around 35% more 
than the control value in hippocampal neuronal culture. Co-treatment with Melissa officinalis significantly reversed 
these damages to around 15% and 20% respectively of the MDMA alone group, and provided protection against 
MDMA-induced mitochondrial dysfunction and apoptosis in neurons. Melissa officinalis has revealed 
neuroprotective effects against apoptosis induced by MDMA in the primary neurons of hippocampal culture, which 
could be due to its free radical scavenging properties and monoamine oxidase (MAO) inhibitory effects[49].Both 
methanolic and aqueous extracts of this plant were tested for protective effects on the PC12 cell line, free radical 
scavenging properties and neurological activities. The results suggest that the plant has a significant (P < 0.05) 
protective effect on hydrogen peroxide induced toxicity in PC12 cells. No activity was detected in the 
acetylcholinesterase and GABA assays. The methanolic extract was more effective than the aqueous [11]. 
 
Anti-depression and anti-anxiety 
The antidepressant-like activity of water extract of this plant was investigated by evaluating its influence on the 
behaviors and the relevant neurotransmitters of rats performed to force swimming test[53]. 
 
The behavioral effects of an acute or subacute orally administered M.officinal is ethanol extract were evaluated in 
male and female Wistar rats in elevated plus-maze, forced swimming and open field tests. The effects of diazepam 
and fluoxetine were also assessed. The potential psychoactive properties of M. officinalis may provide a unique 
pharmacological alternative for certain psychiatric disorders; however, the efficacy seems to be dependent on both 
gender and administration length[54]. 
 
Ina double blind randomized placebo-controlled clinical trial, the efficacy and safety of the dried extract of 
M. officinalis was evaluated on adults suffering from benign palpitations. Results showed that 14-day of treatment 
with lyophilized aqueous extract of M. officinalis leaves reduced frequency of palpitation episodes and significantly 
reduced the number of anxious patients in comparison to the placebo. Besides, M. officinalis extract showed no 
serious side effects.it can be concluded that Lyophilized aqueous extract of M. officinalis leaves may be a proper 
and safe herbal drug for the treatment of benign palpitations [55]. 
 
Chronic administration of Melissa officinalis L. was shown to relieve stress-related effects [33].in addition, in 
another study, the effects of chronic administration of Melissa officinalis L. extract (Cyracos, Naturex)was 
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investigated and it was show that Cyracos has anxiolytic-like effects under moderate stress conditions and does not 
alter activity levels[112] 
 
Melissa officinalis (lemon balm) and Valeriana officinalis (valerian)have been illustrated to decrease laboratory 
induced stress. These results suggest that a combination of Melissa officinalis and Valeriana officinalis possesses 
anxiolytic properties in a dose-dependent manner; however, it needs further study[113]. 
 
Anti-agitation 
Melissa officinalis was shown to inhibit binding of t-butylbicyclophosphorothionate to the rat forebrain gamma-
aminobutyric acid receptor channel, but had no effect on N-methyl-D-aspartate, alpha-amino-3-hydroxy-5-methyl-4-
isoxazolepropianate or nicotinic acetylcholine receptors. Thus, MO cause a significant dose-dependent reduction in 
both inhibitory and excitatory transmission, with a net depressant effect on neurotransmission that is in contrast to 
the classical GABA antagonist picrotoxinin which evoked profound epileptiform burst firing in these cells. The anti-
agitation effects in patients and the depressant effects of MO in in-vitro we report in neural membranes are unlikely 
to reflect a sedative interaction with any of the ionotropic receptors[114]. 
 
It was suggested that leaves of Melissa officinalis L. increases cell proliferation, neuroblast differentiation and 
integration into granule cells by decreasing serum corticosterone levels as well as by increasing GABA levels in the 
mouse DG [30]. 
 
Antimicrobial and antifungal 
The essential oil obtained from leaves of Melissa officinalis L. was investigated for its in vitro antimicrobial activity. 
The results showed that the essential oil presented high antimicrobial activity against all microorganisms targeted 
mainly against five human pathogenic bacteria, one yeast Candida albicans and two phytopathogenic fungi tested. 
[115].in addition, antimicrobial of Melissa officinalis essential oil was investigated and it was shown that the most 
effective antibacterial activity was expressed on a multiresistant strain of Shigellasonei. A significant rate of 
antifungal activity was exhibited on Trichophyton species [25].besides, the antimicrobial properties of essential oil 
from romanian Melissa officinalis were assayed and it was shown a high activity against Candida albicans. The 
gram-negative bacteria were not affected by the lemon balm oil [24].furthermore, antimicrobial activities of the 
extracts and rosmarinic acid of this plant were evaluated and were confirmed [116]. 
 
Insomnia 
Efficacy and tolerability of a combined valerian/lemon balm preparation were investigated in an open, multicenter 
study in children less than 12 years suffering from restlessness and nervous dyskoimesis. Euvegal forte 
was effective in the treatment of younger children with restlessness and dyssomnia and it was very well tolerated 
[62].For the first time, it has been shown that chronic administration of Melissa officinalis L. relieves stress-related 
effects. It is essential that more studies incorporate a placebo and investigate physiological stress markers[33]. 
 
Anticancer 
The antiproliferative and proapoptotic effects of ethanolic leaves extract of Melissa officinalis were investigated in 
human coloncarcinoma cells.it found that Melissa  officinalis  extract  inhibits  the  proliferation  of  colon  
carcinoma  cells and induces apoptosis through formation of ROS[29].the selective anticancer effects of an MO 
extract (MOE)was investigated in different human cancer cells. Results indicated that a hydro-alcoholic extract of 
MO possess a high potency to inhibit proliferation of different tumor cells in a dose independent manner, suggesting 
that an optimal biological dose is more important than a maximally tolerated one. Moreover, the antiproliferative 
effect of MO seems to be tumor type specific, as hormone dependent cancers were more sensitive to antitumoral 
effects of MOE[117].the activity of the M. officinalis essential oil (EO) and its major component (citral) in GBM 
cell lines was examined . Both EO and citral decreased the viability and induced apoptosis of GBM cells as 
demonstrated by DNA fragmentation and caspase-3 activation. the results show that EO, through its major 
component, citral, may be of potential interest for the treatment of GBM[28].it also was suggested that MOE 
increases cell proliferation, neuroblast differentiation and integration into granule cells by 
decreasing serumcorticosterone levels as well as by increasing GABA levels in the mouse DG[30]. 
 
Anti-inflammatory 
The effect of the essential oil of the leaves of this plant was investigated for anti-inflammatory properties by using 
carrageenan and experimental trauma-induced hind paw edema in rats. M. officinalis L. essential oil showed 
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remarkable reduction and inhibition of edema induced by carrageenan at 6 h at 200 and 400 mg/kg with 91.66% and 
94.44%, respectively (P < 0.001). thus, it can be concluded that the essential oil of M. officinalis L. had potential 
anti-inflammatory activities [60]. 
 
Cardiovascular disease 
In a double blind randomized placebo-controlled clinical trial, the efficacy and safety of the dried extract of M. 
officinalis on adults suffering from benign palpitations was evaluated. Fifty-five volunteers out of 71 recruited study 
subjects completed the trial. Results showed that 14-day of treatment with lyophilized aqueous extract of M. 
officinalis leaves reduced frequency of palpitation episodes and significantly reduced the number of anxious patients 
in comparison to the placebo .thus, it can be safely used for the treatment of benign palpitations [55].the influence of 
Melissa officinalis on cardiac conduction and susceptibility to lethal ventricular arrhythmia was assessed and it was 
shown that M. officinalis extract has a mild protective effect against reperfusion-induced lethal ventricular 
arrhythmias in rats[118].The effects of aqueous extract of M. officinalis aerial parts on Wistar rat heart with/without 
cardiac injury was examined and  it was concluded that the lower dose of extract, by improving the balance of the 
redox system and by reducing the heart rate, may increase the heart resistance to injury. However, the higher doses 
of extract may intensify the injury of ischemic heart[57]. 
 
Memory and concentration improving 
The role of cholinergic system on the memory improving activity of M. officinalis extract was investigated. These 
results suggest that M. officinalis can improve memory and that the cholinergic property of the extract may 
contribute to the memory-improving effects observed in this study. Then M. officinalis extract has potential 
therapeutic value in alleviating certain memory impairment observed in AD[58]. 
 
In a clinical trial, it was examined that whether treatment with a fixed combination of Valeria and Melissa may 
improve concentration, hyperactivity and impulsiveness. The fraction of children having strong/very strong 
symptoms of poor ability to focus decreased from 75% to 14%, hyperactivity from 61% to 13%, and impulsiveness 
from 59% to 22%. Parent rated social behavior, sleep and symptom burden showed highly significant 
improvements. Only in two children ,mild transient adverse drug reactions were observed[64]. 
 
Side effects: 
no side effects have so far been reported for the herb [119] When used topically or orally in recommended doses [up 
to 30 days] in otherwise healthy adults and when consumed in amounts found in foods. Lemon balm has been 
assigned Generally Regarded as Safe (GRAS) status in the United States with a maximum level of 0.5% in baked 
goods. 
 • Possibly Unsafe: During pregnancy or lactation or in pediatric patients, and when used in patients with thyroid 
disorders or in combination with sedatives (theoretical)[120]. 
 
CONCLUSION 
 
Melissa officinalis l. is widely used for therapeutic and non-therapeutic purposes that trigger its significant value. 
Various combinations and numerous medicinal properties of its extract,   oil, and leaves demand further and more 
studies about the other useful and unknown properties of this multipurpose plant. 
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